Literature DB >> 6732327

Sclerosing cholangitis. Anatomical distribution of obstructive lesions.

J L Cameron, B W Gayler, H Sanfey, F Milligan, S Kaufman, W C Maddrey, H F Herlong.   

Abstract

The cholangiograms of 36 patients with sclerosing cholangitis were reviewed. The mean age of the patient group was 43 years, and the mean disease duration was 4.5 years. Seventeen of the patients had associated inflammatory bowel disease. The mean serum bilirubin was 6.8 mg/dl, the mean SGOT was 105 IU/L, the mean SGPT was 108 IU/L, and the mean serum alkaline phosphatase was 534 IU/L. The cholangiograms demonstrated involvement of the extrahepatic bile ducts in 33 patients, involvement of the hepatic duct bifurcation in 33 patients, and involvement of the intrahepatic bile ducts in 35 patients. The cholangiograms were graded as to the areas of the most severe obstructive involvement. In 24 patients the area of most severe involvement was the hepatic duct bifurcation. In eight additional patients the hepatic duct bifurcation, along with the extrahepatic ducts and/or the intrahepatic ducts, were felt to be the areas most severely affected. This predilection for severe obstructive disease at the hepatic duct bifurcation in sclerosing cholangitis held for both patients with and without inflammatory bowel disease. Thus, most patients with sclerosing cholangitis have cholangiographic evidence of diffuse extrahepatic and intrahepatic biliary tract disease, with the hepatic duct bifurcation being the area generally most severely affected.

Entities:  

Mesh:

Year:  1984        PMID: 6732327      PMCID: PMC1250392          DOI: 10.1097/00000658-198407000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Percutaneous dilatation in primary sclerosing cholangitis: two experiences.

Authors:  E C Martin; E I Fankuchen; R W Schultz; W J Casarella
Journal:  AJR Am J Roentgenol       Date:  1981-09       Impact factor: 3.959

2.  Primary sclerosing cholangitis: results of an aggressive surgical approach.

Authors:  H A Pitt; H H Thompson; R K Tompkins; W P Longmire
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

3.  Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

Authors:  R H Wiesner; N F LaRusso
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

4.  The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  O Epstein; R W Chapman; G Lake-Bakaar; A Y Foo; S B Rosalki; S Sherlock
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

5.  Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents.

Authors:  J L Cameron; B W Gayler; H F Herlong; W C Maddrey
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

6.  Primary sclerosing cholangitis: a heterogenous disease.

Authors:  H H Thompson; H A Pitt; R K Tompkins; W P Longmire
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

  6 in total
  6 in total

1.  Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation.

Authors:  A C Stieber; I R Marino; S Iwatsuki; T E Starzl
Journal:  Int Surg       Date:  1989 Jan-Mar

2.  Primary sclerosing cholangitis: resect, dilate, or transplant?

Authors:  S A Ahrendt; H A Pitt; A N Kalloo; A C Venbrux; A S Klein; H F Herlong; J Coleman; K D Lillemoe; J L Cameron
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

3.  Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis.

Authors:  J L Cameron; H A Pitt; M J Zinner; H F Herlong; S L Kaufman; J K Boitnott; J Coleman
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

Review 4.  Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature.

Authors:  S H Mir-Madjlessi; R G Farmer; M V Sivak
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

5.  Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.

Authors:  M M Kemeny; H Battifora; D W Blayney; G Cecchi; D A Goldberg; L A Leong; K A Margolin; J J Terz
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

6.  Indications for non-transplant surgery in primary sclerosing cholangitis.

Authors:  Bastian Domajnko; Steven A Ahrendt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.